Volume 8, Number 2—February 2002
Broad-Range Bacterial Detection and the Analysis of Unexplained Death and Critical Illness
|Case ID||Sex||Age (yrs)||Duration of antibiotic therapy before specimen obtained||Clinical syndrome(s)a||16S rDNA PCR and sequencing results||Specimen||Outcome|
|XOR6||M||18||10 min||Neurologic||Neisseria meningitidis||CSF||Survived|
|XOR34||M||13||3 days||Neurologic||N. meningitidis||CSF||Survived|
|XCA73||F||19||1 dayb||Respiratory & neurologic||Streptococcus pneumoniae||CSF||Survived|
|XEB44||F||10||3 days||Respiratory||S. pneumoniae||Pleural fluid||Survived|
|XMN22||M||43||2 weeks||Respiratory||S. pneumoniae||Pleural fluid||Survived|
|XOR63||M||29||1 month||Respiratory||Stenotrophomonas maltophilia||Bone marrow aspirate||Died (no autopsy)|
|XOR56||M||11||none||Multisystem||Staphylococcus epidermidis||Blood culture material||Survived|
|XCT29||F||10||1 week||Cardiac||Bacillus sp., Halomonas sp., Enterococcus sp.||Blood culture material||Survived|
aThe primary clinical syndrome(s) during hospitalization.
bA second cerebrospinal (CSF) sample obtained 5 days later also contained S. pneumoniae rDNA.
Page created: July 14, 2010
Page updated: July 14, 2010
Page reviewed: July 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.